Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 14:06:36 GMT 2023
by
admin
on
Sat Dec 16 14:06:36 GMT 2023
|
Protein Type | RECEPTOR |
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
X6OG5T1C4M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Q99720
Created by
admin on Sat Dec 16 14:06:38 GMT 2023 , Edited by admin on Sat Dec 16 14:06:38 GMT 2023
|
PRIMARY | |||
|
X6OG5T1C4M
Created by
admin on Sat Dec 16 14:06:38 GMT 2023 , Edited by admin on Sat Dec 16 14:06:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
AGONIST -> TARGET |
Ki
|
||
|
AGONIST -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Selective ligand of sigma sites in brain, labelled with (+)-[3 H] 3PPP (K i= 5.3±0.3 nM), were
investigated in rodents.
IC50
|
||
|
AGONIST -> TARGET | |||
|
AGONIST -> TARGET | |||
|
RADIOLIGAND->TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
AGONIST -> TARGET |
(+)-pentazocine is active
|
||
|
INHIBITOR -> TARGET |
Ki
|
||
|
INHIBITOR -> TARGET |
Selective ligand of sigma sites in brain, labelled with (+)-[3 H] 3PPP (K i= 5.3±0.3 nM), were
investigated in rodents.
IC50
|
||
|
INHIBITOR -> TARGET |
Ki
|
||
|
RADIOLIGAND->TARGET | |||
|
AGONIST -> TARGET |
IC50
|
||
|
AGONIST -> TARGET |
|
||
|
RADIOLIGAND->TARGET |
>146,000-fold selectivity over the σ2R and >10,000-fold selectivity over 59 different targets
Ki
|
||
|
INHIBITOR -> TARGET |
|
||
|
AGONIST -> TARGET |
Ki
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|